CHG-2024-0213

New Dosage Strength for Cardilostat. Labeling Change for Cardilostat — major revision. Impacts 3 markets and 1 variations.

Change Number
CHG-2024-0213
Type
New Dosage Strength
Product
Cardilostat
Status
Overdue
Owner
James O'Brien
Initiated
2023-09-21
Description

Labeling Change for Cardilostat — major revision

Impacted Markets (3)
CA — CanadaDE — GermanyTR — Turkey
Impacted Modules
5.3.53.2.S4.2.13.2.P
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved